Literature DB >> 15236847

RSV outbreak in a paediatric intensive care unit.

K Thorburn1, S Kerr, N Taylor, H K F van Saene.   

Abstract

The Royal Liverpool Children's Hospital-Alder Hey paediatric intensive care unit (PICU) usually has a low rate of nosocomial respiratory syncytial virus (RSV) infection. We report and analyse a major outbreak of nosocomial (acquired) RSV infection on the PICU during a RSV season. All children admitted to the PICU were studied during the six-month winter period 1 October 2002 to 31 March 2002. Nasopharyngeal aspirates were tested using an in vitro enzyme-linked immunoassay (ELISA) membrane test for RSV antigen. PICU-acquired RSV infection was considered to have occurred when a child admitted to the PICU was RSV negative, or from whom no samples were taken as they did not exhibit signs of bronchiolitis, but was RSV positive five or more days after the admission. Fifty-four patients tested RSV positive using the ELISA on the PICU. All the patients were ventilated. Thirty-nine children were RSV positive using the ELISA on admission to the PICU ('imported' cases) and 15 became RSV positive whilst on the PICU ('acquired' cases). The source of the acquired RSV infection accounting for the first peak/outbreak in nosocomial cases were RSV-positive children in isolation cubicles. Acquired cases of RSV infection subsided with reinforcement of traditional methods of barrier precautions. The source of the second peak in nosocomial cases were persistent shedders of RSV. Seventy-three percent (11/15) of the acquired RSV cases had one or more of the following co-morbidities: congenital heart disease, chronic lung disease, airways abnormalities or immunosuppression. Droplet precautions (strict handwashing, use of gloves if handling body fluids, single-use aprons, education) rather than the physical barrier of the cubicle itself played a more important role in curtailing nosocomial spread. Persistent shedders of RSV are an important potential source of nosocomial RSV infection within a PICU. Patients with co-morbidities are at increased risk of nosocomial RSV infection.

Entities:  

Mesh:

Year:  2004        PMID: 15236847     DOI: 10.1016/j.jhin.2004.03.013

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  20 in total

1.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

2.  High mortality of invasive pneumococcal disease compared with meningococcal disease in critically ill children.

Authors:  Kentigern Thorburn; Nia Taylor; Lucia Lopez-Rodriguez; Michael Ashworth; Miguel Angel de la Cal; Hendrik Karel Ferdinand van Saene
Journal:  Intensive Care Med       Date:  2005-09-16       Impact factor: 17.440

3.  High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis.

Authors:  K Thorburn; S Harigopal; V Reddy; N Taylor; H K F van Saene
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 4.  Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.

Authors:  X Carbonell-Estrany; L Bont; G Doering; J-B Gouyon; M Lanari
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-16       Impact factor: 3.267

5.  A model of the costs of community and nosocomial pediatric respiratory syncytial virus infections in Canadian hospitals.

Authors:  Philip Jacobs; Douglas Lier; Katherine Gooch; Katharina Buesch; Michelle Lorimer; Ian Mitchell
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

6.  Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?

Authors:  William J Ehlenbach; J Randall Curtis
Journal:  Crit Care Med       Date:  2008-03       Impact factor: 7.598

7.  Respiratory syncytial virus infection in 406 hospitalized premature infants: results from a prospective German multicentre database.

Authors:  Arne Simon; Roland A Ammann; Anja Wilkesmann; Anna M Eis-Hübinger; Oliver Schildgen; Edda Weimann; Hans U Peltner; Peter Seiffert; Angela Süss-Grafeo; Jessie R Groothuis; Johannes Liese; Ralf Pallacks; Andreas Müller
Journal:  Eur J Pediatr       Date:  2007-02-16       Impact factor: 3.183

Review 8.  Best practice in the prevention and management of paediatric respiratory syncytial virus infection.

Authors:  Simon B Drysdale; Christopher A Green; Charles J Sande
Journal:  Ther Adv Infect Dis       Date:  2016-02-10

9.  Respiratory virus shedding in a cohort of on-duty healthcare workers undergoing prospective surveillance.

Authors:  Jennifer C Esbenshade; Kathryn M Edwards; Adam J Esbenshade; Vanessa E Rodriguez; H Keipp Talbot; Marlon F Joseph; Samuel K Nwosu; James D Chappell; James E Gern; John V Williams; Thomas R Talbot
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-08       Impact factor: 3.254

10.  Respiratory syncytial virus infection in children with neuromuscular impairment.

Authors:  Arne Simon; Julia Prusseit; Andreas Müller
Journal:  Open Microbiol J       Date:  2011-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.